Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

TEXAS NEUROFIBROMATOSIS FOUNDATION

Filed by VAN SCOYOC ASSOCIATES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 19, 2026
Income
Not reported
Expenses
Not reported
Filing UUID
a05d73d1-20fc-46b1-965a-582034e447ac
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/s.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/s.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Literal federal measure citations: H.R.4016, s.2572, H.R.5304, s.2587

DEF · Defense

H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026, Medical research issues and Neurofibromatosis provisions

Literal federal measure citations: H.R.4016, S.2572

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.